dehydroabietic acid has been researched along with fluorouracil in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 7 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Huang, XC; Pan, YM; Tian, XY; Wang, HS; Wang, M; Zhang, Y | 1 |
Huang, XC; Pan, YM; Qin, JK; Tian, XY; Wang, HS; Wang, M; Yao, GY; Zhang, Y | 1 |
Chen, ZF; Huang, XC; Pan, YM; Wang, HS; Wang, M; Zhang, Y | 1 |
Chen, ZF; Huang, XC; Jin, L; Liang, D; Pan, YM; Wang, HS; Wang, M; Zhang, Y | 1 |
Gou, S; Huang, R; Huang, X; Liao, Z; Pan, Y; Wang, H | 1 |
Fan, X; Jiang, B; Li, Y; Liu, L; Xu, H; Zhang, G | 1 |
Huang, RZ; Huang, XC; Liang, GB; Liao, ZX; Wang, HS; Zhang, B; Zhou, MM | 1 |
7 other study(ies) available for dehydroabietic acid and fluorouracil
Article | Year |
---|---|
Synthesis and antitumor activities of novel α-aminophosphonates dehydroabietic acid derivatives.
Topics: Abietanes; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Survival; Drug Evaluation, Preclinical; Flow Cytometry; Humans; Inhibitory Concentration 50; Molecular Structure; Organophosphonates | 2013 |
Synthesis and antitumor activities of novel thiourea α-aminophosphonates from dehydroabietic acid.
Topics: Abietanes; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Hep G2 Cells; Humans; Molecular Structure; Organophosphonates; Structure-Activity Relationship; Thiourea | 2013 |
Synthesis and antitumor activities of novel dipeptide derivatives derived from dehydroabietic acid.
Topics: Abietanes; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Dipeptides; DNA Fragmentation; Drug Screening Assays, Antitumor; HCT116 Cells; HeLa Cells; Humans; Phenanthrenes; Phenylalanine; Reactive Oxygen Species | 2014 |
Design, synthesis and in vitro evaluation of novel dehydroabietic acid derivatives containing a dipeptide moiety as potential anticancer agents.
Topics: Abietanes; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Survival; Cytochromes c; Dipeptides; Drug Design; Flow Cytometry; Humans; In Situ Nick-End Labeling; Membrane Potential, Mitochondrial; Microscopy, Fluorescence; Molecular Structure; Reactive Oxygen Species | 2015 |
Synthesis and pharmacological evaluation of dehydroabietic acid thiourea derivatives containing bisphosphonate moiety as an inducer of apoptosis.
Topics: Abietanes; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Proliferation; Cell Survival; Diphosphonates; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Structure-Activity Relationship; Thiourea; Tumor Cells, Cultured | 2016 |
Identification of a diverse synthetic abietane diterpenoid library for anticancer activity.
Topics: Abietanes; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Membrane Potential, Mitochondrial; Molecular Structure; Structure-Activity Relationship | 2017 |
Discovery of dehydroabietic acid sulfonamide based derivatives as selective matrix metalloproteinases inactivators that inhibit cell migration and proliferation.
Topics: Abietanes; Antineoplastic Agents; Cell Line, Tumor; Cell Movement; Cell Proliferation; Dose-Response Relationship, Drug; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Molecular Docking Simulation; Molecular Structure; Structure-Activity Relationship; Sulfonamides | 2017 |